Insulin-like Growth Factors Market
完整報告名稱與涵蓋範圍
Insulin-like Growth Factors Market Share & Trends Analysis Report, By Type (Mechano Growth Factor, Somatomedin C, IGF 1), By End-user (Hospitals, Medical Centers), By Region, and Segment Forecasts, 2023-2031
報告摘要
The worldwide Insulin-like Growth Factors Market stood at USD 275.1 Mn in 2023, and is projected to reach USD 406.1 Mn by 2031, recording a CAGR of 5.13% from 2024 through 2031.
At its core, Insulin-like Growth Factors pertains to proteins that resemble insulin in structure and share some of its effects. Stakeholders across the healthcare landscape are escalatingly turning to these solutions to meet contemporary demands.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the escalating emphasis on efficiency and sustainability within the healthcare sector.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Insulin-like Growth Factors Market Snapshot
Chapter 4. Global Insulin-like Growth Factors Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Mechano Growth Factor
5.2.2. Somatomedin C
5.2.3. IGF 1
Chapter 6. Market Segmentation 2: by End-users Estimates & Trend Analysis
6.1. by End-users & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-users:
6.2.1. Hospitals
6.2.2. Medical Centers
Chapter 7. Insulin-like Growth Factors Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.1.2. North America Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031
7.1.3. North America Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.2. Europe
7.2.1. Europe Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.2.2. Europe Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031
7.2.3. Europe Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.3.2. Asia Pacific Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031
7.3.3. Asia Pacific Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.4. Latin America
7.4.1. Latin America Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.4.2. Latin America Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031
7.4.3. Latin America Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
7.5.2. Middle East & Africa Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031
7.5.3. Middle East & Africa Insulin-like Growth Factors Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Boehringer Ingelheim International GmbH
8.2.2. Genervon Biopharmaceuticals LLC
8.2.3. Ascendis Pharma
8.2.4. Regulaxis SAS
8.2.5. MedImmune, LLC
8.2.6. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們